A nurse is reinforcing teaching about a biophysical profile with a client who is at 40 weeks of gestation. The nurse should explain that this profile focuses on which of the following parameters? (Select all that apply.)
Fetal breathing
Fetal motion
Nuchal translucency
Amniotic fluid volume
Fetal gender
The Correct Answer and Explanation is:
Correct Answers:
- ✅ Fetal breathing
- ✅ Fetal motion
- ✅ Amniotic fluid volume
Incorrect Answers:
- ❌ Nuchal translucency
- ❌ Fetal gender
Explanation (300+ words):
A biophysical profile (BPP) is a noninvasive prenatal test used primarily in the third trimester to assess fetal well-being and detect potential complications. It combines ultrasound imaging and non-stress testing (NST) to evaluate five critical biophysical parameters that reflect fetal health. These components provide information about the central nervous system, oxygenation status, and risk for hypoxia.
Here are the five parameters assessed in a biophysical profile:
- Fetal Breathing Movements:
The fetus demonstrates rhythmic breathing-like motions. These movements suggest that the fetal brainstem is functioning properly, which is an indicator of oxygenation and neurological health. - Fetal Movements (Fetal Motion):
The fetus is expected to show active body or limb movements. A reduction in movements could indicate fetal distress or hypoxia. - Fetal Tone:
This refers to the fetus making flexion and extension movements, such as curling or uncurling limbs. Like breathing and motion, it also reflects central nervous system integrity. - Amniotic Fluid Volume:
Adequate levels of amniotic fluid are essential for fetal development and cushion the fetus. Low fluid (oligohydramnios) can indicate chronic placental insufficiency or fetal renal issues. - Non-Stress Test (NST):
This component uses fetal heart rate monitoring to evaluate accelerations in response to fetal movements. A reactive NST indicates good oxygenation.
Each parameter is given a score of 0 (abnormal) or 2 (normal) for a total possible score of 10. A score of 8–10 is generally considered reassuring.
Nuchal translucency is not part of the BPP; it is measured in the first trimester to assess the risk of chromosomal abnormalities like Down syndrome. Fetal gender also has no clinical relevance in determining fetal well-being and is not assessed in a biophysical profile.
In conclusion, a BPP at 40 weeks focuses on fetal breathing, fetal motion, fetal tone, amniotic fluid volume, and the non-stress test—excluding parameters like nuchal translucency and fetal gender.